• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oracle Enhances Electronic Data Capture Solution to Streamline Clinical Trials and Help Bring New Therapies to Market Faster

    8/27/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology
    Get the next $ORCL alert in real time by email

    Updates include AI-enabled EHR interoperability, comprehensive data collection, and safety integration capabilities

    AUSTIN, Texas, Aug. 27, 2025 /PRNewswire/ -- Oracle today introduced significant advancements to its Electronic Data Capture (EDC) solution, Oracle Clinical One Data Collection. These new capabilities enable seamless interoperability with Electronic Health Record (EHR) systems, enhance data collection capabilities at trial sites, and provide end-to-end integration with Oracle Safety One Argus and other safety solutions. These updates are designed to simplify clinical workflows and eliminate data friction across systems to help accelerate research, improve safety reporting, and bring therapies to market faster.

    (PRNewsfoto/Oracle)

    These advancements, developed in collaboration with pharma industry leaders and Oracle's CRO Growth Network collaborators, reflect Oracle's commitment to delivering AI-driven, interoperable solutions that enhance automation, streamline data connectivity, and offer customers greater choice and flexibility.

    "In today's complex clinical trial landscape, interoperability and streamlined data flow are paramount," said Deepu Joseph, Global Head of DM, Country Head India, Excelya. "Oracle's focus on agnostic EHR-EDC integration and complete safety reporting within Clinical One Data Collection increases operational efficiency for sites and sponsors. This kind of robust, connected ecosystem is exactly what the industry needs, to reduce burden and accelerate studies."

    Comprehensive EHR integration

    Furthering Oracle's mission to deliver a connected and intelligent clinical research ecosystem, the new EDC enhancements enable researchers to use the AI-enabled Oracle Clinical Connector to securely transfer data between Oracle Health and other EHRs and Oracle Clinical One Data Collection. This integration removes manual busywork by enabling direct, EHR data transfers that can help improve accuracy and speed research.

    Site and subject-level data and document management

    While structured data captured through eCRFs is essential, modern clinical research also requires the flexibility to collect and manage other types of data. The new release increases document management capabilities for clinical sites with site-level data collection to support all file formats at the subject level, allowing documents to be uploaded alongside structured data within the EDC system. For example, site staff can use a mobile device to upload contextual data directly into the platform, such as a subject's scanned lab result. This helps teams keep documentation centralized, supports a more complete view of the subject, and accelerates research workflows.

    Integration with safety solutions

    Reporting serious adverse events often requires duplicative effort across disconnected systems, which can slow research, is prone to inaccurate entries, and risks quality. Clinical One Data Collection now offers integrated safety capabilities across the workflow for faster and more accurate adverse event management. The safety integration uses the ICH E2B(R3) standard, enabling sites to more quickly and seamlessly address their regulatory compliance obligations to immediately report the occurrence of serious adverse events (SAE) to the trial sponsor. The integration is fully interoperable with Oracle Safety One Argus and other safety solutions, giving customers choice and flexibility, while helping to maintain compliance and efficiency across the clinical development lifecycle.

    "Our EDC enhancements underscore Oracle's commitment to delivering AI-driven capabilities and aligning clinical research and clinical care by creating a more open healthcare ecosystem that fuels medical breakthroughs for the patients who desperately need them," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "These innovations in data collection and safety can help further streamline drug development, to help improve data integrity and regulatory adherence, while empowering researchers to conduct trials with efficiency and precision."

    The new features and enhancements within Oracle Clinical One Data Collection are available to customers globally as part of their standard clinical update process.

    To learn more about how Oracle is transforming clinical trials with innovative solutions designed to unify data from clinical trials, streamline and automate safety case management, generate real-world evidence from unique data sets, and guide brand strategy with commercial insights visit https://www.oracle.com/life-sciences/ or join us at the Oracle Health and Life Sciences Summit in Orlando, September 9-11, 2025, to see the solutions in action. Register now at: https://www.oracle.com/health/health-life-sciences-summit/.

    About Oracle Life Sciences

    Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements, empowering the Life Sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

    About Oracle

    Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.

    Trademarks

    Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-enhances-electronic-data-capture-solution-to-streamline-clinical-trials-and-help-bring-new-therapies-to-market-faster-302539257.html

    SOURCE Oracle

    Get the next $ORCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ORCL

    DatePrice TargetRatingAnalyst
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    1/12/2026$240.00Buy
    Goldman
    12/11/2025$355.00 → $270.00Outperform
    BMO Capital Markets
    12/3/2025$280.00Overweight
    Wells Fargo
    11/10/2025Buy → Hold
    Erste Group
    10/13/2025$345.00 → $355.00Outperform
    BMO Capital Markets
    10/9/2025$365.00Outperform
    Robert W. Baird
    9/25/2025$175.00Sell
    Rothschild & Co Redburn
    More analyst ratings

    $ORCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $205.00 from $270.00 previously

    2/4/26 7:57:19 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Goldman resumed coverage on Oracle with a new price target

    Goldman resumed coverage of Oracle with a rating of Buy and set a new price target of $240.00

    1/12/26 8:18:29 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    BMO Capital Markets reiterated coverage on Oracle with a new price target

    BMO Capital Markets reiterated coverage of Oracle with a rating of Outperform and set a new price target of $270.00 from $355.00 previously

    12/11/25 8:00:07 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fairhead Rona Alison bought $112,258 worth of shares (480 units at $233.87), increasing direct ownership by 2% to 22,110 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    7/9/25 4:39:51 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Boskin Michael J bought $111,145 worth of shares (1,682 units at $66.08), increasing direct ownership by 2% to 92,458 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    3/21/25 8:43:30 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moorman Charles W bought $947,913 worth of shares (5,500 units at $172.35) (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/14/25 4:41:16 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by EVP, Chief Legal Officer Levey Stuart

    4 - ORACLE CORP (0001341439) (Issuer)

    1/26/26 5:15:41 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    EVP, Principal Financial Offcr Kehring Douglas A sold $6,821,150 worth of shares (35,000 units at $194.89), decreasing direct ownership by 51% to 33,638 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    1/16/26 4:15:34 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Pres., Global Field Operations Hura Mark gifted 5,000 shares and sold $2,953,314 worth of shares (15,000 units at $196.89), decreasing direct ownership by 8% to 234,077 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    12/29/25 5:33:47 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care

    Lumeo Regional Health Information System will leverage Oracle Health's voice-enabled, note generation technology to streamline clinical documentation and enhance care delivery AUSTIN, Texas, Feb. 4, 2026 /PRNewswire/ -- Lumeo Regional Health Information System (Lumeo RHIS) in Southeastern Ontario has selected Oracle Health Clinical AI Agent for a pilot project to streamline clinical documentation and reduce physicians' administrative workload so they can focus more time on caring for the people they serve. Representing six healthcare organizations across the region, the system's selection of Oracle Health Clinical AI Agent, an AI-powered, voice-enabled solution, builds on its mission of lev

    2/4/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer

    NEW YORK, Feb. 3, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 3rd Stocks are mixed as investors track a heavy week of corporate earnings — including reports from NYSE‑listed Pfizer, Eaton, Uber, and Eli Lilly — while labor data is disrupted by the postponement of Friday's January Jobs Report due to the partial government shutdown.With government data delayed, market attention is shifting to private‑sector indicators and corporate outlook

    2/3/26 8:55:00 AM ET
    $ICE
    $ORCL
    $TYL
    Investment Bankers/Brokers/Service
    Finance
    Computer Software: Prepackaged Software
    Technology

    Oracle Reimagines Banking for the AI Era with New Agentic Platform

    Enables retail banks to elevate customer experiences and operational efficiency, helping position them for leadership in the new landscape of intelligent, AI-first banking NEW YORK, Feb. 3, 2026 /PRNewswire/ -- Oracle Financial Services Summit -- Oracle Financial Services is transforming banking with an enterprise-class suite of AI-infused applications, design tools, frameworks and pre-built AI agents. With these advancements, banks can benefit from intelligent, conversational interfaces and autonomous AI agents. These capabilities allow financial institutions to better understand and anticipate customers' evolving needs and deliver hyper-personalized service whether the customer is banking

    2/3/26 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    SEC Filings

    View All

    SEC Form CERT filed by Oracle Corporation

    CERT - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:24:57 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form 8-A12B filed by Oracle Corporation

    8-A12B - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:18:28 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

    8-K - ORACLE CORP (0001341439) (Filer)

    2/5/26 4:01:31 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Financials

    Live finance-specific insights

    View All

    Oracle Announces Fiscal Year 2026 Second Quarter Financial Results

    Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI

    12/10/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Sets the Date for its Second Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on December 10, 2025, After the Close of the Market AUSTIN, Texas, Dec. 2, 2025 /PRNewswire/ -- Oracle Corporation today announced that its second quarter fiscal year 2026 results will be released on Wednesday, December 10th, after the close of the market.  Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor.  About Oracle Oracle offers integrated suites of applications plus secure, a

    12/2/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle Corporation Announces Promotion of Clay Magouyrk and Mike Sicilia to CEOs; Safra Catz Appointed Executive Vice Chair of the Board of Directors

    AUSTIN, Texas, Sept. 22, 2025 /PRNewswire/ -- Oracle Corporation (NYSE:ORCL) today announced the promotion of Clay Magouyrk and Mike Sicilia to the roles of Chief Executive Officers.  Clay Magouyrk, previously President, Oracle Cloud Infrastructure (OCI), joined Oracle in 2014 from Amazon Web Services. As a founding member of Oracle's cloud engineering team, Clay has overseen the design, implementation and business success of Gen2 of OCI. Oracle Cloud Infrastructure Gen2 is a high-performance, secure, cost-efficient platform that powers both hyperscale public cloud datacenters

    9/22/25 8:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Leadership Updates

    Live Leadership Updates

    View All

    Health Systems Simplify Secure Data Exchange with Oracle Health

    New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems can easily manage a broad range of interoperability services Early adopters see 50 percent reduction in processing times of Social Security Administration disability benefit claims AUSTIN, Texas, Oct. 9, 2025 /PRNewswire/ -- Oracle Health Connection Hub is now generally available for U.S. healthcare providers, enabling them to use a single console to more easily onboard, access, and manage preferences for Oracle Health interoperability solutions. The latest step in Oracle's strategy to increase interoperability and reduce friction between payers and pr

    10/9/25 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SoftBank Group to Acquire Ampere Computing

    SoftBank Group Corp. (TSE: 9984, "SoftBank Group") today announced that it will acquire Ampere® Computing, a leading independent silicon design company, in an all-cash transaction valued at $6.5 billion. Under the terms of the agreement, Ampere will operate as a wholly owned subsidiary of SoftBank Group and retain its name. As part of the transaction, Ampere's lead investors – Carlyle (NASDAQ:CG) and Oracle Corp. (NYSE:ORCL) – are selling their respective positions in Ampere. As SoftBank Group broadens its AI infrastructure investments in ventures such as Cristal intelligence and Stargate, the acquisition will help enhance SoftBank Group's capabilities in key areas and accelerate its growt

    3/19/25 7:30:00 PM ET
    $CG
    $ORCL
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Oracle Launches AI-powered Oracle Analytics Intelligence for Life Sciences

    Life sciences, academic medical centers, health systems, and research institutes can gain insights into diseases and their impact on patients to optimize therapeutic launch strategies Pre-built and continuously updated analytics platform has unprecedented variety of real-world data sources, including CancerMPact and multiomics NASHVILLE, Tenn., Oct. 30, 2024 /PRNewswire/ -- Oracle Health Summit -- Oracle today launched Oracle Analytics Intelligence for Life Sciences. The AI-powered, cloud-scale, data and analytics platform streamlines and helps accelerate insight generation by unifying disparate data sets into a single, intelligent workbench. The new solution empowers users to answer multidi

    10/30/24 9:00:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $ORCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/9/24 4:33:37 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/23 4:31:02 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Oracle Corporation (Amendment)

    SC 13G/A - ORACLE CORP (0001341439) (Subject)

    2/10/22 8:28:11 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology